KCER will present a July 16, 2020 webinar for dialysis facilities on The Basics of Preparing an After-Action Report for an Incident or Disaster. The webinar presents KCER’s template for After-Action Reports (“AAR”) and includes instructions for meeting the CMS Emergency Preparedness Rule for dialysis facilities, and specific guidance for AARs on your response to COVID-19. Find more information in the flyer below. Click HERE to register. Contact KCER at email@example.com questions or assistance.
An AAR describes an event or process that for any reason you needed or wanted to respond to or improve, how you responded, your evaluation of the effectiveness of your response, and any improvements you recommend for “next time,” or to complete or enhance your response to the current issue.
The CDC MMWR has published a document entitled Assessing Solid Organ Donors and Monitoring Transplant Recipients for HIV, HBV, and HCV Infection — U.S. Public Health Service Guideline, 2020., describing advances in infection detection and treatment since the previous 2013 edition, with recommendations for organ procurement organizations and transplant centers. It doesn’t cover COVID-19 organ damage or transmission. Find the Guideline at https://www.cdc.gov/mmwr/volumes/69/rr/rr6904a1.htm?s_cid=rr6904a1_w.
After you register, you will receive an e-mail containing a unique webinar link and audio details. Do not share the link, as it will be unique to you. If more than one staff member at your facility would like to attend, and you can maintain safe social distancing, you may join as a team. The webinar will cover:
How to access and review your facility’s PSR and PLR.
How CMS calculated your QIP performance scores.
What your TPS means to your facility’s 2021 reimbursement.
The FDA has announced a Class II recall of 212 cases of Diasol 1000225-10-DEX100 Liquid Acid Concentrate for Bicarbonate Hemodialysis, UDIs B467100225101004 and B4671000225101004, Lot PHQ03041/030920, because of mislabeling. They were distributed in California. For details see https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=181559.